Alpha DNA Investment Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-70,323
Closed -$542K 243
2024
Q1
$542K Buy
+70,323
New +$542K 0.2% 113